The last several years have seen significant progress in the development of vaccines
against malaria. Most recently, proof-of-concept of vaccine-induced protection from malaria …

Background Surrogate markers of protective immunity to malaria in humans are needed to
rationalize malaria vaccine discovery and development. In an effort to identify such markers …

Background Plasmodium falciparum merozoite surface protein (MSP) 3 is an asexual blood-
stage malaria vaccine candidate antigen. Sequence polymorphisms divide alleles into 2 …

Clinical experiments have shown that the Ab-dependent cell-mediated inhibition of
Plasmodium falciparum is a major mechanism controlling malaria parasitemia and thereby …

The glutamate-rich protein (GLURP) of P. falciparum is the target of cytophilic antibodies
which are significantly associated with protection against clinical malaria. A phase 1 clinical …

Many studies on the role of merozoite surface protein 3 (MSP3) in immunity against malaria
have focused on a conserved section of MSP3. New evidence suggests that polymorphic …

The merozoite surface protein-3 long synthetic peptide (MSP3-LSP) comprises the amino
acid sequence 186–276 of the Plasmodium falciparum protein MSP3. It is currently in …

Background In malaria endemic areas children may recover from malaria after
chemotherapy in spite of harbouring genotypically drug-resistant Plasmodium falciparum …

The aim of this study was to assess the immunoglobulin (Ig)‐subclass distribution of
antimalarial antibody responses in 110 and 169 Thai patients with complicated and …

Background Burma records the highest number of malaria deaths in southeast Asia and may
represent a reservoir of infection for its neighbors, but the burden of disease and magnitude …